Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy
- PMID: 9543458
Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy
Similar articles
-
Reduction in oropharyngeal candidiasis following introduction of protease inhibitors.AIDS. 1998 Mar 5;12(4):447-8. AIDS. 1998. PMID: 9520182 No abstract available.
-
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.Clin Infect Dis. 2005 Nov 15;41(10):1473-80. doi: 10.1086/497373. Epub 2005 Oct 12. Clin Infect Dis. 2005. PMID: 16231260 Clinical Trial.
-
Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.AIDS. 1998 Dec 24;12(18):2513-4. AIDS. 1998. PMID: 9875599 No abstract available.
-
The diagnosis and treatment of candidiasis: current therapeutic options.AIDS Patient Care STDS. 1997 Feb;11 Suppl 1:S10-4; discussion S15. AIDS Patient Care STDS. 1997. PMID: 11361745 Review. No abstract available.
-
[Fluconazole (Diflucan): its clinical spectrum and development].Rev Clin Esp. 1997 Apr;197 Suppl 1:86-93. Rev Clin Esp. 1997. PMID: 9297211 Review. Spanish. No abstract available.
Cited by
-
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066).Infection. 2013 Sep;41 Suppl 2(Suppl 2):S91-115. doi: 10.1007/s15010-013-0504-1. Epub 2013 Sep 14. Infection. 2013. PMID: 24037688 Free PMC article.
-
Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatment.Drugs. 2004;64(11):1163-80. doi: 10.2165/00003495-200464110-00002. Drugs. 2004. PMID: 15161325 Review.
-
Immune Reconstitution and the Consequences for Opportunistic Infection Treatment and Prevention.Curr Infect Dis Rep. 1999 Apr;1(1):99-104. doi: 10.1007/s11908-999-0016-4. Curr Infect Dis Rep. 1999. PMID: 11095773
-
Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis.Int J Antimicrob Agents. 2023 Sep;62(3):106906. doi: 10.1016/j.ijantimicag.2023.106906. Epub 2023 Jun 29. Int J Antimicrob Agents. 2023. PMID: 37392947 Free PMC article.
-
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.Microbiol Mol Biol Rev. 2003 Sep;67(3):400-28, table of contents. doi: 10.1128/MMBR.67.3.400-428.2003. Microbiol Mol Biol Rev. 2003. PMID: 12966142 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical